Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Urothelial Carcinoma
100%
Potential Clinical Applications
100%
Telomerase Reverse Transcriptase Promoter mutation
100%
Urine Samples
33%
C228T
33%
C250T
33%
Molecular Mechanism
16%
Carcinoma
16%
Human Cancer
16%
Telomerase
16%
Melanoma
16%
Human Telomerase Reverse Transcriptase (hTERT)
16%
Histological Grade
16%
Invasiveness
16%
Sanger Sequencing
16%
Non-associated
16%
Cystectomy
16%
Tumor Location
16%
Blood Samples
16%
Genetic Modification
16%
Lower Urinary Tract
16%
Point mutation
16%
Site of Origin
16%
Promoter Region
16%
Telomerase Activity
16%
Upper Urinary Tract
16%
Urothelium
16%
Cystitis
16%
Lymphovascular Invasion
16%
Bladder Cancer Cell Lines
16%
Nephrogenic Adenoma
16%
Type Sequences
16%
Inverted Papilloma
16%
Recurrent Point
16%
Pathological Implications
16%
Invasive Status
16%
Benign Lesions
16%
Polymerase Chain Reaction Amplification
16%
Benign Bladder Lesions
16%
Medicine and Dentistry
Promoter Region
100%
Telomerase Reverse Transcriptase
100%
Transitional Cell Carcinoma
100%
Telomerase
33%
Urine Sampling
33%
Neoplasm
16%
Cancer
16%
Carcinoma
16%
Sanger Sequencing
16%
Cystectomy
16%
Urinary Tract
16%
Cystitis
16%
Bladder Injury
16%
Gene Mutation
16%
Adenoma
16%
Point Mutation
16%
Urothelium
16%
Lymphovascular Invasion
16%
Bladder Cancer Cell Line
16%
Melanoma
16%
Inverted Papilloma
16%
Polymerase Chain Reaction
16%